Free Trial
→ I warned you about Nvidia… now look what’s happening (From Timothy Sykes) (Ad)
LON:4BB

4basebio 5/27/2025 Earnings Report

4basebio logo
GBX 991 +26.00 (+2.69%)
As of 11:33 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 0.94
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Date
5/27/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4BASEBIO UK SOCIETAS (4BB) - Investing.com UK
July 12, 2025  |  uk.investing.comhttps://uk.investing.com/equities/4basebio-uk-societas-historical-data
4basebio Plc - Director Appointment, Board Change
July 8, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-07/65852080-4basebio-plc-director-appointment-board-change-008.htm
BREAKING: The House just passed 3 pro-crypto bills!
Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the country are buzzing in anticipation
July 24 at 2:00 AM  |  Crypto 101 Media (Ad)
4basebio Appoints Dr. Manja Boerman as Executive Chair Amid Board Changes
July 8, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-appoints-dr-manja-boerman-as-executive-chair-amid-board-changes?utm_source=marketbeat.com&utm_medium=referral
4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies - Morningstar
July 2, 2025  |  morningstar.comM
4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies - Business Wire
July 2, 2025  |  businesswire.comhttps://www.businesswire.com/news/home/20250701500315/en/4basebio-Introduces-New-Branding-to-Reflect-Next-Phase-of-Growth-Enabling-Development-of-Advanced-Genetic-Therapies
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile

More Earnings Resources from MarketBeat

Earnings Tools
Earnings By Country
Latest Articles